![Martin Pfister](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin Pfister
Director/Miembro de la Junta en WMT AG .
Perfil
Dr. Martin Pfister studied medicine and pharmacy at the University of Greifswald and New York University and received his doctorate in immunology.
He worked in various academic laboratories.
Since 2000 he has been active in the start-up scene.
He took over management positions and is co-founder of two successful companies in the fields of diagnostics & health services.
In 2010 he transferred to the HTGF on the investor side.
With his long-standing experience in drug development/gene therapy and medical technology/diagnostics, he is a valued sparring partner for portfolio companies in the fields of biotechnology and healthcare.
He also holds several advisory board positions with portfolio companies.
Cargos activos de Martin Pfister
Empresas | Cargo | Inicio |
---|---|---|
High-Tech Gründerfonds Management GmbH
![]() High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Inversor de Capital Privado | 12/05/2011 |
OMEICOS Therapeutics GmbH
![]() OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Director/Miembro de la Junta | - |
WMT AG
![]() WMT AG Miscellaneous Commercial ServicesCommercial Services WMT AG is a German research company that specializes in developing cancer therapies. WMT was founded in 2020 by Yves Guillermet and Claus Kremoser, with Claus Kremoser serving as the CEO since 2020. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Martin Pfister.
Empresas | Cargo | Fin |
---|---|---|
Data Information Intelligence GmbH | Fundador | 31/10/2018 |
Formación de Martin Pfister.
Universität Leipzig | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 4 |
---|---|
OMEICOS Therapeutics GmbH
![]() OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Health Technology |
WMT AG
![]() WMT AG Miscellaneous Commercial ServicesCommercial Services WMT AG is a German research company that specializes in developing cancer therapies. WMT was founded in 2020 by Yves Guillermet and Claus Kremoser, with Claus Kremoser serving as the CEO since 2020. | Commercial Services |
Data Information Intelligence GmbH | |
High-Tech Gründerfonds Management GmbH
![]() High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Finance |
- Bolsa de valores
- Insiders
- Martin Pfister